B. Riley restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Get Rating) in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a $12.00 price objective on the stock. B. Riley also issued estimates for PDS Biotechnology’s Q1 2023 earnings at ($0.36) EPS, Q2 2023 earnings at ($0.38) […]
HC Wainwright reaffirmed their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Get Rating) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $21.00 target price on the stock. HC Wainwright also issued estimates for PDS Biotechnology’s Q1 2023 earnings at ($0.25) EPS, Q2 2023 earnings at ($0.25) […]
PDS Biotechnology (NASDAQ:PDSB – Get Rating)‘s stock had its “buy” rating reaffirmed by investment analysts at B. Riley in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $12.00 target price on the stock. B. Riley’s price target indicates a potential upside of 91.69% from the company’s previous close. Several […]
PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating) – Equities research analysts at HC Wainwright issued their FY2027 EPS estimates for PDS Biotechnology in a research note issued to investors on Tuesday, January 3rd. HC Wainwright analyst J. Pantginis forecasts that the company will post earnings of $0.63 per share for the year. HC Wainwright has […]